Published in Lancet on December 29, 1973
The frontiers of cardiomyopathy. Br Heart J (1982) 1.98
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J (1981) 1.46
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart (2005) 1.24
Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study. Br Heart J (1982) 1.04
The role of echocardiography in the investigation of focal cerebral ischaemia. Postgrad Med J (1984) 0.98
Nonobstructive and obstructive hypertrophic cardiomyopathies. West J Med (1979) 0.94
Pathological features of hypertrophic obstructive cardiomyopathy (HOCM) in the elderly. Br Heart J (1975) 0.92
Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs. Br Heart J (1982) 0.91
Cardiac arrhythmias in hypertrophic cardiomyopathy. Br Heart J (1982) 0.87
Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J (1980) 0.86
Comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in Korea. Korean J Intern Med (2005) 0.86
Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J (1994) 0.85
Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy. Br Heart J (1980) 0.84
On predictors of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 0.83
Hypertrophic cardiomyopathy associated with left ventricular aneurysm and normal coronary arteries: Case study indicating genetic tendencies of cardiomyopathy. Cardiovasc Dis (1981) 0.80
Hypertrophic cardiomyopathy in the elderly. Br Heart J (1990) 0.80
Editorial: Sudden death in children with heart disease. Br Med J (1975) 0.78
Syncope in hypertrophic cardiomyopathy. Br Heart J (1982) 0.78
Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson (2016) 0.77
Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy. Postgrad Med J (1996) 0.75
Surgical treatment of hypertrophic obstructive cardiomyopathy in the elderly. Postgrad Med J (1981) 0.75
ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy. Arrhythm Electrophysiol Rev (2016) 0.75
Arrhythmia in hypertrophic cardiomyopathy. Br Med J (1980) 0.75
Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment. Neth Heart J (2005) 0.75
Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy. Br Heart J (1982) 0.75
Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance. Int J Cardiovasc Imaging (2016) 0.75
Career prospects in cardiology in England and Wales. Survey and 15 health regions. Br Heart J (1981) 8.82
Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet (1994) 3.18
The cardiomyopathies. Br Heart J (1972) 3.14
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J (1977) 2.18
Acute rheumatic fever and carditis in older adults. Lancet (1966) 2.01
The frontiers of cardiomyopathy. Br Heart J (1982) 1.98
Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96
Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet (1967) 1.93
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91
Prospects and predictions for the cardiomyopathies. Circulation (1974) 1.87
Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J (1979) 1.86
Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease. Br Heart J (1969) 1.86
The spectrum of cardiac tumors. Am J Cardiol (1968) 1.72
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72
Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med (1983) 1.62
Left ventricular angiography on exercise. A new method of assessing left ventricular function in ischaemic heart disease. Br Heart J (1976) 1.60
Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53
Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Br Med J (1966) 1.53
Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet (1970) 1.51
Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J (1978) 1.50
The colorimetric determination of iron in biological material with reference to its measurement during chelation therapy. Clin Chem (1966) 1.49
Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation (1978) 1.48
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J (1981) 1.46
Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. Eur Heart J (1987) 1.45
Early embryo cleavage is a strong indicator of embryo quality in human IVF. Hum Reprod (2001) 1.42
Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol (1980) 1.30
Regional left ventricular wall movement in hypertrophic cardiomyopathy. Br Heart J (1978) 1.29
Punishment of doctors must fit their crime. BMJ (1998) 1.27
Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy. Lancet (1976) 1.27
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol (1984) 1.26
Echocardiographic features of eosinophilic endomyocardial disease. Br Heart J (1982) 1.24
Transplantation of the heart. Am Heart J (1969) 1.23
Studies in acute iron poisoning. I. Desferrioxamine in the treatment of acute iron poisoning: clinical observations, experimental studies, and theoretical considerations. Pediatrics (1965) 1.23
Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.23
Approach to the estimation of myocardial infarct size by analysis of precordial S-T segment and R wave maps. Am J Cardiol (1978) 1.22
Hydralazine in the management of left ventricular failure. Am J Cardiol (1979) 1.21
Treatment of the cardiomyopathies. Am J Cardiol (1973) 1.20
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J (1980) 1.20
Urgent aortic-valve replacement for acute aortic regurgitation due to infective endocarditis. Lancet (1971) 1.20
Trophectoderm morphology: an important parameter for predicting live birth after single blastocyst transfer. Hum Reprod (2011) 1.19
Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J (1973) 1.17
Electrophysiological manifestations of non-penetrating cardiac trauma. Br Heart J (1980) 1.12
Successful surgical treatment of two patients with eosinophilic endomyocardial disease. Br Heart J (1981) 1.12
Double outlet right ventricle with pulmonary stenosis. Br Heart J (1967) 1.10
Targeting cell cycle and hormone receptor pathways in cancer. Oncogene (2013) 1.10
Left ventricular volume and hypertrophy in outflow obstruction. Cardiovasc Res (1968) 1.08
Q waves and coronary angiography in cardiomyopathy. Br Heart J (1970) 1.08
Direct measurement of serum iron and binding capacity. Clin Chem (1966) 1.08
Spectrophotometry of proline in plasma and urine. Clin Chem (1972) 1.07
Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet (1981) 1.06
The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation (1982) 1.06
Echocardiographic features of tropical endomyocardial disease in South India. Br Heart J (1983) 1.04
Obstetric outcomes after transfer of vitrified blastocysts. Hum Reprod (2010) 1.04
Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study. Br Heart J (1982) 1.04
The challenge and the reproach of infective endocarditis. Br Heart J (1985) 1.02
Hypertrophic cardiomyopathy: a disease in search of its own identity. Am J Cardiol (1980) 1.02
Hypertrophy and obstruction of outflow tract of left ventricle. Br Heart J (1970) 1.01
The natural history of hypertrophic cardiomyopathy. Curr Probl Cardiol (1981) 1.00
Q waves and coronary arteriography in cardiomyopathy. Br Heart J (1972) 0.99
ABC of sports medicine. Sudden death in sport. BMJ (1994) 0.99
Long-term follow-up of atrial myxoma. Br Heart J (1972) 0.97
Delayed closure of the pulmonary valve in obliterative pulmonary hypertension. Lancet (1965) 0.96
Detection of perioperative myocardial damage after coronary artery bypass graft surgery. Circulation (1977) 0.95
The epidemiology of right bundle branch block and its association with cardiovascular morbidity--the Reykjavik Study. Eur Heart J (1993) 0.95
An appreciation of hypertrophic cardiomyopathy. Am J Med (1980) 0.95
No evidence that embryo selection by near-infrared spectroscopy in addition to morphology is able to improve live birth rates: results from an individual patient data meta-analysis. Hum Reprod (2014) 0.95
Mechanisms in cardiomyopathies. J Mol Cell Cardiol (1985) 0.94
Ventricular septal defect and aortic regurgitation. Thorax (1969) 0.93
Preimplantation genetic diagnosis (PGD): the Gothenburg experience. Acta Obstet Gynecol Scand (2001) 0.93
Disorders of the outflow tract of the left ventricle. Br Med J (1967) 0.92
The colorimetric estimation of plasma amino nitrogen with DNFB. Clin Chem (1968) 0.92
Method for simultaneous direct estimation of glucose and xylose in serum. Clin Chem (1970) 0.92
Arrhythmias in dilated and hypertrophic cardiomyopathy. Med Clin North Am (1984) 0.91
Ventricular dysrhythmias in middle-aged hypertensive men treated either with a diuretic agent or a beta-blocker. Acta Med Scand (1987) 0.91
Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs. Br Heart J (1982) 0.91
Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study. J Am Coll Cardiol (1985) 0.90
Ventricular structure and function after radical correction of the tetralogy of Fallot. Br Heart J (1967) 0.90
Quantification of protein solutions with trinitrobenzenesulfonic acid. Clin Chem (1970) 0.90
Investigation and treatment of constrictive pericarditis. Thorax (1967) 0.90
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. Hypertrophic cardiomyopathy can be treated but not cured. BMJ (1995) 0.89
Usefulness of preoperative and postoperative Tc-99m (Sn)-pyrophosphate scans in patients with ischemic and valvular heart disease. Am J Cardiol (1977) 0.89
The relationship of myocarditis to dilated cardiomyopathy. Eur Heart J (1984) 0.88
Spectrum of cardiomyopathy and current classification. Singapore Med J (1973) 0.88
Results of attempted cardiopulmonary resuscitation of patients dying suddenly outside the hospital in Reykjavik and the surrounding area, 1976-1979. Acta Med Scand (1982) 0.87
Two decades of atrial tumour. Eur Heart J (1982) 0.87
The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med (1999) 0.87
Congestive cardiomyopathy. Introduction, problems and aims of the Multicentre Research Project. Postgrad Med J (1978) 0.87
Ventricular aneurysm. An appraisal of diagnosis and surgical treatment. Br Heart J (1972) 0.87
Cardiac arrhythmias in hypertrophic cardiomyopathy. Br Heart J (1982) 0.87
Predictors of ongoing implantation in IVF in a good prognosis group of patients. Hum Reprod (2005) 0.86
Increasing glucose levels and BMI predict future heart failure experience from the Reykjavík Study. Eur J Heart Fail (2007) 0.86
Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J (1980) 0.86
Mitral regurgitation in congestive cardiomyopathy. Postgrad Med J (1968) 0.86
Isovolumic relaxation period in hypertrophic cardiomyopathy. J Am Coll Cardiol (1984) 0.86
Hypertrophic diseases of the myocardium. Prog Cardiovasc Dis (1973) 0.86
Quantification of serum inorganic phosphorus, phosphatase, and urinary phosphate without preliminary treatment. Clin Chem (1970) 0.86